{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:53:03Z","timestamp":1788457983337,"version":"build-2803163510"},"reference-count":40,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>POEMS syndrome is defined by the presence of a peripheral neuropathy (P), a monoclonal plasma cell disorder (M), and other paraneoplastic features, the most common of which include organomegaly (O), endocrinopathy (E), skin changes (S), papilledema, edema, effusions, ascites, and thrombocytosis. Virtually all patients will have either sclerotic bone lesion(s) or co-existent Castleman\u2019s disease. Not all features of the disease are required to make the diagnosis, and early recognition is important to reduce morbidity. Other names for the syndrome include osteosclerotic myeloma, Crow-Fukase syndrome, or Takatsuki syndrome. Because the peripheral neuropathy is frequently the overriding symptom and because the characteristics of the neuropathy are similar to that chronic inflammatory demyelinating polyneuropathy (CIDP), patients are frequently misdiagnosed with CIDP or monoclonal gammopathy of underdetermined significance (MGUS)-associated peripheral neuropathy. Not until additional features of the POEMS syndrome are recognized is the correct diagnosis made and effective therapies initiated. Clues to an early diagnosis include thrombocytosis and sclerotic bone lesions on plain skeletal radiographs. Therapies that may be effective in patients with CIDP and MGUS-associated peripheral neuropathy (intravenous gammaglobulin and plasmapheresis) are not effective in patients with POEMS. Instead, the mainstays of therapy for patients with POEMS include irradiation, corticosteroids, and alkylator-based therapy, including high-dose chemotherapy with peripheral blood stem cell transplantation.<\/jats:p>","DOI":"10.1182\/asheducation-2005.1.360","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T20:29:34Z","timestamp":1132691374000},"page":"360-367","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":77,"title":["POEMS Syndrome"],"prefix":"10.1182","volume":"2005","author":[{"given":"Angela","family":"Dispenzieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111701435711000_R1","doi-asserted-by":"crossref","unstructured":"Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med. 1994;97:543\u2013553.","DOI":"10.1016\/0002-9343(94)90350-6"},{"key":"2019111701435711000_R2","doi-asserted-by":"crossref","unstructured":"Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984;34:712\u2013720.","DOI":"10.1212\/WNL.34.6.712"},{"key":"2019111701435711000_R3","doi-asserted-by":"crossref","unstructured":"Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101:2496\u20132506.","DOI":"10.1182\/blood-2002-07-2299"},{"key":"2019111701435711000_R4","doi-asserted-by":"crossref","unstructured":"Crow R. Peripheral neuritis in myelomatosis. Br Med J. 1956;2:802\u2013804.","DOI":"10.1136\/bmj.2.4996.802"},{"key":"2019111701435711000_R5","doi-asserted-by":"crossref","unstructured":"Iwashita H, Ohnishi A, Asada M, Kanazawa Y, Kuroiwa Y. Polyneuropathy, skin hyperpigmentation, edema, and hypertrichosis in localized osteosclerotic myeloma. Neurology. 1977;27:675\u2013681.","DOI":"10.1212\/WNL.27.7.675"},{"key":"2019111701435711000_R6","doi-asserted-by":"crossref","unstructured":"Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine. 1980;59:311\u2013322.","DOI":"10.1097\/00005792-198007000-00006"},{"key":"2019111701435711000_R7","doi-asserted-by":"crossref","unstructured":"Sung JY, Kuwabara S, Ogawara K, Kanai K, Hattori T. Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve. 2002;26:189\u2013193.","DOI":"10.1002\/mus.10182"},{"key":"2019111701435711000_R8","doi-asserted-by":"crossref","unstructured":"Vital C, Vital A, Ferrer X, et al. Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases. J Peripher Nerv Syst. 2003;8:136\u2013144.","DOI":"10.1046\/j.1529-8027.2003.03019.x"},{"key":"2019111701435711000_R9","doi-asserted-by":"crossref","unstructured":"Belec L, Mohamed AS, Authier FJ, et al. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman\u2019s disease. Blood. 1999;93:3643\u20133653.","DOI":"10.1182\/blood.V93.11.3643"},{"key":"2019111701435711000_R10","doi-asserted-by":"crossref","unstructured":"Sasano T, Sakurai SI, Hara Y. Improvement in gonadotropin secretion after corticosteroid therapy in a case of POEMS syndrome. Endo J. 1998;45:413\u2013419.","DOI":"10.1507\/endocrj.45.413"},{"key":"2019111701435711000_R11","doi-asserted-by":"crossref","unstructured":"Shichiri M, Iwashina M, Imai T, Marumo F, Hirata Y. Abnormal FSH hypersecretion as an endocrinological manifestation of POEMS syndrome. Endo J. 1998;45:131\u2013134.","DOI":"10.1507\/endocrj.45.131"},{"key":"2019111701435711000_R12","doi-asserted-by":"crossref","unstructured":"Gherardi R, Baudrimont M, Kujas M, et al. Pathological findings in three non-Japanese patients with the POEMS syndrome. Virchows Arch A Pathol Anat Histopathol. 1988;413:357\u2013365.","DOI":"10.1007\/BF00783029"},{"key":"2019111701435711000_R13","doi-asserted-by":"crossref","unstructured":"Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. 2004;104:3400\u20133407.","DOI":"10.1182\/blood-2004-05-2046"},{"key":"2019111701435711000_R14","doi-asserted-by":"crossref","unstructured":"Bolling JP, Brazis PW. Optic disk swelling with peripheral neuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS syndrome). Am J Ophthalmol. 1990;109:503\u2013510.","DOI":"10.1016\/S0002-9394(14)70678-6"},{"key":"2019111701435711000_R15","doi-asserted-by":"crossref","unstructured":"Lesprit P, Godeau B, Authier FJ, et al. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am J Respir Crit Care Med. 1998;157:907\u2013911.","DOI":"10.1164\/ajrccm.157.3.9707095"},{"key":"2019111701435711000_R16","doi-asserted-by":"crossref","unstructured":"Lesprit P, Authier FJ, Gherardi R, et al. Acute arterial obliteration: a new feature of the POEMS syndrome? Medicine. 1996;75:226\u2013232.","DOI":"10.1097\/00005792-199607000-00005"},{"key":"2019111701435711000_R17","doi-asserted-by":"crossref","unstructured":"Nakamoto Y, Imai H, Yasuda T, Wakui H, Miura AB. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant. 1999;14:2370\u20132378.","DOI":"10.1093\/ndt\/14.10.2370"},{"key":"2019111701435711000_R18","doi-asserted-by":"crossref","unstructured":"Soubrier M, Sauron C, Souweine B, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis. 1999;34:633\u2013638.","DOI":"10.1016\/S0272-6386(99)70386-0"},{"key":"2019111701435711000_R19","doi-asserted-by":"crossref","unstructured":"Bergouignan FX, Massonnat R, Vital C, et al. Uncompacted lamellae in three patients with POEMS syndrome. Eur Neurol. 1987;27:173\u2013181.","DOI":"10.1159\/000116152"},{"key":"2019111701435711000_R20","unstructured":"Soubrier M, Labauge P, Jouanel P, Viallard JL, Piette JC, Sauvezie B. Restricted use of Vlambda genes in POEMS syndrome. Haematologica. 2004;89:ECR02."},{"key":"2019111701435711000_R21","doi-asserted-by":"crossref","unstructured":"Belec L, Authier FJ, Mohamed AS, Soubrier M, Gherardi RK. Antibodies to human herpesvirus 8 in POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes) syndrome with multicentric Castleman\u2019s disease. Clin Infect Dis. 1999;28:678\u2013679.","DOI":"10.1086\/515169"},{"key":"2019111701435711000_R22","doi-asserted-by":"crossref","unstructured":"Gherardi RK, Belec L, Soubrier M, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood. 1996;87:1458\u20131465.","DOI":"10.1182\/blood.V87.4.1458.bloodjournal8741458"},{"key":"2019111701435711000_R23","doi-asserted-by":"crossref","unstructured":"Hitoshi S, Suzuki K, Sakuta M. Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease. Intern Med. 1994;33:583\u2013587.","DOI":"10.2169\/internalmedicine.33.583"},{"key":"2019111701435711000_R24","doi-asserted-by":"crossref","unstructured":"Rose C, Zandecki M, Copin MC, et al. POEMS syndrome: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells. Leukemia. 1997;11:1318\u20131323.","DOI":"10.1038\/sj.leu.2400733"},{"key":"2019111701435711000_R25","unstructured":"Feinberg L, Temple D, de Marchena E, Patarca R, Mitrani A. Soluble immune mediators in POEMS syndrome with pulmonary hypertension: case report and review of the literature. Crit Rev Oncog. 1999;10:293\u2013302."},{"key":"2019111701435711000_R26","doi-asserted-by":"crossref","unstructured":"Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve. 2000;23:1051\u20131056.","DOI":"10.1002\/1097-4598(200007)23:7<1051::AID-MUS7>3.0.CO;2-V"},{"key":"2019111701435711000_R27","doi-asserted-by":"crossref","unstructured":"Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve. 1998;21:1390\u20131397.","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4"},{"key":"2019111701435711000_R28","doi-asserted-by":"crossref","unstructured":"Soubrier M, Dubost JJ, Serre AF, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum. 1997;40:786\u2013787.","DOI":"10.1002\/art.1780400430"},{"key":"2019111701435711000_R29","doi-asserted-by":"crossref","unstructured":"Michizono K, Umehara F, Hashiguchi T, et al. Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome. Neurology. 2001;56:807\u2013810.","DOI":"10.1212\/WNL.56.6.807"},{"key":"2019111701435711000_R30","unstructured":"Takatsuki K, Sanada I. Plasma cell dyscrasia with polyneur-opathy and endocrine disorder: clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol. 1983;13:543\u2013555."},{"key":"2019111701435711000_R31","doi-asserted-by":"crossref","unstructured":"Hogan WJ, Lacy MQ, Wiseman GA, Fealey RD, Dispenzieri A, Gertz MA. Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2001;28:305\u2013309.","DOI":"10.1038\/sj.bmt.1703108"},{"key":"2019111701435711000_R32","doi-asserted-by":"crossref","unstructured":"Sternberg AJ, Davies P, Macmillan C, Abdul-Cader A, Swart S. Strontium-89: a novel treatment for a case of osteoscle-rotic myeloma associated with life-threatening neuropathy. Br J Haematol. 2002;118:821\u2013824.","DOI":"10.1046\/j.1365-2141.2002.03692.x"},{"key":"2019111701435711000_R33","doi-asserted-by":"crossref","unstructured":"Kuwabara S, Hattori T, Shimoe Y, Kamitsukasa I. Long term melphalan-prednisolone chemotherapy for POEMS syndrome. J Neurol Neurosurg Psychiatry. 1997;63:385\u2013387.","DOI":"10.1136\/jnnp.63.3.385"},{"key":"2019111701435711000_R34","doi-asserted-by":"crossref","unstructured":"Wong VA, Wade NK. POEMS syndrome: an unusual cause of bilateral optic disk swelling. Am J Ophthalmol. 1998;126:452\u2013454.","DOI":"10.1016\/S0002-9394(98)00106-8"},{"key":"2019111701435711000_R35","doi-asserted-by":"crossref","unstructured":"Soubrier M, Ruivard M, Dubost JJ, Sauvezie B, Philippe P. Successful use of autologous bone marrow transplantation in treating a patient with POEMS syndrome. Bone Marrow Transplant. 2002;30:61\u201362.","DOI":"10.1038\/sj.bmt.1703600"},{"key":"2019111701435711000_R36","doi-asserted-by":"crossref","unstructured":"Peggs KS, Paneesha S, Kottaridis PD, et al. Peripheral blood stem cell transplantation for POEMS syndrome. Bone Marrow Transplant. 2002;30:401\u2013404.","DOI":"10.1038\/sj.bmt.1703670"},{"key":"2019111701435711000_R37","doi-asserted-by":"crossref","unstructured":"Jaccard A, Royer B, Bordessoule D, Brouet JC, Fermand JP. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood. 2002;99:3057\u20133059.","DOI":"10.1182\/blood.V99.8.3057"},{"key":"2019111701435711000_R38","doi-asserted-by":"crossref","unstructured":"Rovira M, Carreras E, Blade J, et al. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol. 2001;115:373\u2013375.","DOI":"10.1046\/j.1365-2141.2001.03040.x"},{"key":"2019111701435711000_R39","doi-asserted-by":"crossref","unstructured":"Sinisalo M, Hietaharju A, Sauranen J, Wirta O. Thalidomide in POEMS syndrome: case report. Am J Hematol. 2004;76:66\u201368.","DOI":"10.1002\/ajh.20051"},{"key":"2019111701435711000_R40","doi-asserted-by":"crossref","unstructured":"Dispenzieri A, Suarez GA, Kyle RA. POEMS syndrome (osteosclerotic myeloma). In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy (ed 4th). Philadelphia: Elsevier Saunders; 2005:2453\u20132469.","DOI":"10.1016\/B978-0-7216-9491-7.50112-5"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2005\/1\/360\/645214\/360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2005\/1\/360\/645214\/360.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T01:44:15Z","timestamp":1573955055000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2005\/1\/360\/19304\/POEMS-Syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2005.1.360","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,1]]}}}